Predictive Insights for Precision Medicine: The Global Biosimulation Market is Set to Hit USD 10 billion by 2030
The Global Biosimulation Market Size was valued at USD 2.9 billion in 2022 and is expected to reach USD 10.0 billion by 2030, registering a CAGR of 16.9% during the forecast period. The growth of the biosimulation market is being driven by the increasing use of biosimulation in a variety of applications, such as drug discovery, clinical trials, and toxicity prediction.
The biosimulation market has experienced rapid growth and is poised for further expansion. It combines principles from biology, pharmacology, mathematics, and computer science to simulate and predict the behavior of biological systems. Biosimulation enables researchers to gain valuable insights into drug-target interactions, pharmacokinetics, toxicology, and disease progression in a cost-effective and time-efficient manner.
Stay Ahead with Market Intelligence Get Free Sample Copy@ https://www.persistencemarketresearch.com/samples/3726
Market Drivers and Challenges
• Growing Drug Development Costs: The high costs associated with traditional drug development processes have driven the demand for cost-effective and efficient alternatives like biosimulation.
• Increasing Regulatory Support: Regulatory authorities are recognizing the potential of biosimulation in enhancing drug development and patient safety, leading to increased adoption and support.
• Advancements in Computational Technologies: Technological advancements, such as improved computing power and sophisticated modeling algorithms, have enabled more accurate and detailed simulations, driving the growth of the biosimulation market.
• Focus on Personalized Medicine: Biosimulation enables the customization of treatment strategies based on individual patient characteristics, aligning with the growing emphasis on personalized medicine.
• Complex Model Development: Building accurate and reliable models for complex biological systems remains a challenge, requiring expertise in biology, mathematics, and computational sciences.
• Data Availability and Quality: The availability of high-quality data is crucial for accurate simulations. However, accessing comprehensive and reliable data can be a challenge, especially for rare diseases or novel drug targets.
• Regulatory Acceptance: Despite increasing regulatory support, the acceptance and integration of biosimulation into regulatory frameworks worldwide can still pose challenges.
• Validation and Verification: Validating and verifying simulation models against real-world data and clinical outcomes is essential to establish their reliability and gain wider adoption.
Market Key Players
• Certara, L.P
• Simulations Plus, Inc..
• Dassault Systemes SE
• Schrodinger, Inc
• Advanced Chemistry Development, Inc.
• Entelos, Inc.
• Evidera, Inc.
• Genedata AG
• Leadscope Inc
• Acceryls Inc.
Discuss Implications for Your Industry Request Customized Research@ https://www.persistencemarketresearch.com/request-customization/3726
The biosimulation market can be segmented based on the following factors:
By Product and Services
• Software: This segment includes various modeling and simulation software used for biosimulation, such as pharmacokinetic/pharmacodynamic (PK/PD) modeling software, molecular modeling software, and trial design software.
• Services: Services encompass consulting, contract research, and other support services related to biosimulation.
• Drug Discovery and Development: Biosimulation plays a crucial role in predicting drug efficacy, optimizing dosage regimens, and reducing the risk of adverse effects during the drug development process.
• Preclinical Testing: It aids in predicting the safety and effectiveness of potential drug candidates before they enter clinical trials, thereby reducing costs and minimizing risks.
• Clinical Trials: Biosimulation can help design and optimize clinical trials, improving patient selection criteria, and enhancing trial success rates.
• Others (Personalized Medicine, Regulatory Approval, etc.)
By End User
• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations (CROs)
• Academic and Research Institutes
• Regulatory Authorities
If You Want To Know The Business Opportunity/Market Value, Purchase The Premium Insight @ https://www.persistencemarketresearch.com/checkout/3726
Sure, here are some recent developments of companies
• Certara, a leading provider of biosimulation software and services, announced in 2022 that it had acquired Simulation Plus, another provider of biosimulation software and services. This acquisition will allow Certara to offer a more comprehensive suite of biosimulation products and services to its customers.
• Dassault Systèmes, a global leader in 3D design software, announced in 2022 that it had launched a new biosimulation platform called Biovia Life Sciences Discovery Platform. This platform combines Dassault Systèmes' 3D design software with biosimulation capabilities to help pharmaceutical companies and other life sciences organizations to accelerate their drug discovery and development processes.
• Schrödinger, a leading provider of biosimulation software, announced in 2022 that it had launched a new software product called Schrödinger Maestro. This product is designed to make biosimulation more accessible to a wider range of users, including scientists, engineers, and students.
• Advanced Chemistry Development (ACD), a leading provider of chemical informatics software, announced in 2022 that it had acquired Chemical Computing Group, another provider of chemical informatics software. This acquisition will allow ACD to offer a more comprehensive suite of chemical informatics products and services to its customers.
Request you to Read More-
Persistence Market Research's Expertise in Life Sciences and Transformational Health
Our expert team of industry analysts comprising management graduates, medical professionals, engineers, and project managers provides insights on emerging therapy areas, diagnostic tools, medical devices and components, reimbursement and market access, biotechnology, and life science research products and services to equip decision-makers with sound inputs and strategic recommendations. Click here to learn more about how we zero in on the critical aspects of this industry.
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Predictive Insights for Precision Medicine: The Global Biosimulation Market is Set to Hit USD 10 billion by 2030 here
News-ID: 3109433 • Views: 562
More Releases from Persistence Market Research Pvt. Ltd
Innovative Rehabilitation Technologies Drive Growth in Stroke Rehabilitation Mar …
Stroke Rehabilitation Market Size The global stroke rehabilitation market size was valued at US$ 266.4 million in 2021 and is expected to grow at a CAGR of 9% from 2022 to 2032. Revenue generated from the sales of stroke rehabilitation solutions will surge to US$ 679.6 Million by the end of 2032. The growth of the market is being driven by the increasing incidence of strokes, the growing demand for innovative rehabilitation
Launch of New Laser-Based Devices by Key Players Fueling Growth of Global Aesthe …
Market Study on Aesthetic Lasers The aesthetic lasers market reached US$2.8 billion in global revenue in 2021, and it will continue to expand quickly, with a value CAGR of 6.4%, to reach US$5.5 billion by the end of 2032. The growth of the market is being driven by the increasing demand for minimally invasive cosmetic procedures, rising disposable income, technological advancements, and growing medical tourism. Stay Ahead with Market Intelligence Get Free
Wheelchair and Components Market: Growing Demand for Lightweight and Smart Wheel …
Wheelchair and Components Market The global wheelchair and components market is projected to reach USD 17.9 billion by 2033, at a CAGR of 3.7% from 2022-2033. The growth of the market is driven by the increasing prevalence of disabilities, the rising geriatric population, and technological advancements in wheelchair design and manufacturing. Click Here to Get Free Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/12961 The global wheelchair and components market has witnessed significant growth in
Power Quality Equipment Market Set to Surge, Projected to Reach USD 46.1 billion …
Power Quality Equipment Market The global power quality equipment market is projected to reach USD 46.1 billion by 2026, at a CAGR of 7.3% from 2021. The growth of the market is driven by the increasing demand for power quality improvement in industrial, commercial, and residential applications. The rising adoption of renewable energy sources and the growing need for uninterrupted power supply are also contributing to the growth of the market. Click
More Releases for Biosimulation
Global Biosimulation Market to witness digitized satiation
In the process of biosimulation, the computer aided mathematical models are used to simulate the biological processes. Biosimulation is an important part of systems biology and helps in the discovery and development of new drugs, in the area of drug metabolism and in the modeling of biomedical systems that are complex. There is a growing demand for reduction in the cost of discovery of new drugs and the risk of failure
The Biosimulation Market to Be Driven By Neurotechnology
The Biosimulation Market is slated to grow unstoppably in the years to come. The healthcare providers are, of late, making way for more specialized and timely treatment through same-day surgeries, outpatient surgeries, and likewise. ASCs (Ambulatory Surgical Centers) are preferred over conventional hospital settings. As such, cost-effective medical services could be provided. This type of customization is expected to take the healthcare vertical by storm in the future. In the process
The Biosimulation Market to stick to digitized innovation
The Biosimulation Market taught to grow sporadically shortly. With improvement in machine-powered analytics, the healthcare vertical is bound to substantiate therein. Machine learning does make caregivers able of putting data to use, thereby enhancing patients’ outcomes along with overall efficiency. This would be the trend in the healthcare vertical going forward. Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/methodology/3726 In the process of biosimulation, the computer aided mathematical models are used to simulate
Biosimulation Market Study: An Emerging Hint of Opportunity
Latest released the research study on Global Biosimulation Market, offers a detailed overview of the factors influencing the global business scope. Biosimulation Market research report shows the latest market insights, current situation analysis with upcoming trends and breakdown of the products and services. The report provides key statistics on the market status, size, share, growth factors of the Biosimulation. The study covers emerging player’s data, including: Certara, L.P., Simulations Plus,
Biosimulation Market Growth and Sales Forecast 2016 - 2014
Global Biosimulation Market: Overview Biosimulation refers to the mathematical simulation of biological processes and systems. It is aided by computer and is used for model based calculation of biological systems and processes. TMR’s latest report forecasts strong growth for the global biosimulation market between 2011 and 2018. The market is expected to significantly gain from the increasing use of pharmacokinetic (PKPD) and pharmacodynamics, of which PKPD is the most widely used
Biosimulation Market Size, Industry Analysis & Forecast Report 2017
Biosimulation Market Outlook To 2024 ReportsMonitor.com has added the report, “Biosimulation Market Outlook To 2024: Key Categories (Software, Services), by Application, by End-Use, Regional Segmentation, Pipeline Analysis, Competitive Dynamics, And Segment Forecast” extend across over 103 pages, the far reaching research study offers a 360-degree analysis of the market crosswise over different unequivocal elements, including market share by segmentation type, cost analysis, market effect factors, and marketing strategy and promoting methodology. The